These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Overcoming barriers for intra-articular delivery of disease-modifying osteoarthritis drugs. Gao J; Xia Z; Mary HB; Joseph J; Luo JN; Joshi N Trends Pharmacol Sci; 2022 Mar; 43(3):171-187. PubMed ID: 35086691 [TBL] [Abstract][Full Text] [Related]
45. The current state of the osteoarthritis drug development pipeline: a comprehensive narrative review of the present challenges and future opportunities. Kim H; Seo J; Lee Y; Park K; Perry TA; Arden NK; Mobasheri A; Choi H Ther Adv Musculoskelet Dis; 2022; 14():1759720X221085952. PubMed ID: 36504595 [TBL] [Abstract][Full Text] [Related]
46. Location-independent analysis of structural progression of osteoarthritis-Taking it all apart, and putting the puzzle back together makes the difference. Eckstein F; Buck R; Wirth W Semin Arthritis Rheum; 2017 Feb; 46(4):404-410. PubMed ID: 27717491 [TBL] [Abstract][Full Text] [Related]
47. What is new in pharmacological treatment for osteoarthritis? Gezer HH; Ostor A Best Pract Res Clin Rheumatol; 2023 Jun; 37(2):101841. PubMed ID: 37302928 [TBL] [Abstract][Full Text] [Related]
48. Considerations when designing a disease-modifying osteoarthritis drug (DMOAD) trial using radiography. Hellio Le Graverand MP; Clemmer RS; Brunell RM; Hayes CW; Miller CG; Vignon E Semin Arthritis Rheum; 2013 Aug; 43(1):1-8. PubMed ID: 23290692 [TBL] [Abstract][Full Text] [Related]
49. Imaging in osteoarthritis: what have we learned and where are we going? Hayashi D; Guermazi A; Crema MD; Roemer FW Minerva Med; 2011 Feb; 102(1):15-32. PubMed ID: 21317846 [TBL] [Abstract][Full Text] [Related]
51. KARAOKE: Krill oil versus placebo in the treatment of knee osteoarthritis: protocol for a randomised controlled trial. Laslett LL; Antony B; Wluka AE; Hill C; March L; Keen HI; Otahal P; Cicuttini FM; Jones G Trials; 2020 Jan; 21(1):79. PubMed ID: 31937352 [TBL] [Abstract][Full Text] [Related]
52. 18F-NaF simultaneous PET/MRI in osteoarthritis: Initial observations with case illustration. Jena A; Goyal N; Vaishya R J Clin Orthop Trauma; 2021 Nov; 22():101569. PubMed ID: 34513587 [TBL] [Abstract][Full Text] [Related]
53. IL4-10 Fusion Protein Shows DMOAD Activity in a Rat Osteoarthritis Model. van Helvoort EM; de Visser HM; Lafeber FPJG; Coeleveld K; Versteeg S; Weinans HH; Popov-Celeketic J; Eijkelkamp N; Mastbergen SC Cartilage; 2021 Dec; 13(2_suppl):1155S-1164S. PubMed ID: 34159843 [TBL] [Abstract][Full Text] [Related]
54. Latest advancements in imaging techniques in OA. Hayashi D; Roemer FW; Link T; Li X; Kogan F; Segal NA; Omoumi P; Guermazi A Ther Adv Musculoskelet Dis; 2022; 14():1759720X221146621. PubMed ID: 36601087 [TBL] [Abstract][Full Text] [Related]
55. Candidates for Intra-Articular Administration Therapeutics and Therapies of Osteoarthritis. Toyoda E; Maehara M; Watanabe M; Sato M Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808364 [TBL] [Abstract][Full Text] [Related]
56. OARSI/OMERACT criteria of being considered a candidate for total joint replacement in knee/hip osteoarthritis as an endpoint in clinical trials evaluating potential disease modifying osteoarthritic drugs. Dougados M; Hawker G; Lohmander S; Davis AM; Dieppe P; Maillefert JF; Gossec L J Rheumatol; 2009 Sep; 36(9):2097-9. PubMed ID: 19738220 [TBL] [Abstract][Full Text] [Related]
57. MR-Imaging in Osteoarthritis: Current Standard of Practice and Future Outlook. Ehmig J; Engel G; Lotz J; Lehmann W; Taheri S; Schilling AF; Seif Amir Hosseini A; Panahi B Diagnostics (Basel); 2023 Aug; 13(15):. PubMed ID: 37568949 [TBL] [Abstract][Full Text] [Related]